Supplemental Methods

Measurement of BP and subclinical CVD
At the sixth examination cycle, BP levels were measured twice on the participant's left arm by a Heart Study physician using a mercury column sphygmomanometer and a cuff of appropriate size, after the participant has been seated in a chair for ≥5 minutes. The assessment of subclinical disease traits is described below. To determine the ankle-brachial index (ABI), BP was measured twice on both the arms and at both the ankles, using an 8-MHz Doppler pen probe and an ultrasonic Doppler flow detector (Park Medical Electronics Inc., Shaw, Aloha, Ore), as described in the detail elsewhere.
1 ABI was calculated as the average systolic BP of both ankles divided by the average systolic BP of the arms. (Table S1) . 3 
LV fractional shortening (defined as ([LVEDD -LV end-systolic diameter]/LVEDD)
and visually assessed ejection fraction served as measures of LV systolic function. The excellent reproducibility of our echocardiographic measurements has been previously reported. 4 In addition, a 12-lead electrocardiogram was obtained with participants in supine position. Sex-specific Cornell voltage criteria were used to assess electrocardiographic evidence of LV hypertrophy. 3, 5 Ultrasound of the carotid arteries was performed as described previously. 6 Images of the common carotid artery and of the internal carotid artery were obtained using a 7.5-MHz transducer and a 5.0-MHz transducer, respectively. 6 These images were used to calculate near-and far-wall intima media thickness (IMT). The reproducibility of these measurements was good. 7 Stenoses of the carotid arteries were likewise assessed, with greater 25% stenoses indicating significant narrowing of the carotid artery. IMT values that met or exceeded the sex-specific 80 th percentile were defined as increased carotid artery IMT (Table S1 ). 3 Urinary albumin and creatinine were measured in a spot urine sample obtained in the morning.
Urine albumin was assayed using an immunoturbidimetric test (Tinaquant Albumin assay, Roche Diagnostics), urinary creatinine was determined with a modified Jaffe method. Interassay coefficients of variation for urinary albumin and urinary creatinine assays were 7.2% and 2.3%, respectively.
8
Subclinical disease score
We quantified the cumulative subclinical disease burden by generating a subclinical disease score as reported previously. 3 A detailed description of the score is provided in Table S1 . In essence, this score is the sum of five dichotomized indices of subclinical atherosclerosis and target organ damage: LV hypertrophy (by ECG or echocardiography); LV systolic dysfunction (by echocardiography), abnormal ultrasound of the carotid arteries (increased IMT or carotid artery stenosis), peripheral artery disease (abnormal ABI) and glomerular endothelial dysfunction (as indicated by microalbuminuria). 3 Thus, the score ranged from 0 (none of the above abnormal) to 5 (all abnormal). In addition to this score, we evaluated the 5 individual components of the score. We also modeled subclinical disease as a binary variable (yes/no). The complete score and its components were available in a subgroup of 1915 participants.
Supplemental Tables   Table S1. Definitions of subclinical vascular disease* 3
Characteristic
Definition of subclinical disease component
Cut points for subclinical disease presence used in the present study LV hypertrophy by electrocardiography or echocardiography LV hypertrophy by Cornell criteria using electrocardiography Sum of the R-wave in a VL and the S wave in lead V3 exceeding 2.8 mV in men and 2.0 mV in women. 5 Presence of LV hypertrophy by Cornell criteria using electrocardiography or a heightadjusted LV mass using echocardiography that met or exceeded the sex-specific 80th percentile 9 LV hypertrophy by echocardiography LV mass was calculated as 0. 8 
Carotid ultrasound abnormality
Increased carotid artery IMT
A composite measure that combined the maximal common carotid artery IMT and maximal internal carotid artery IMT was obtained by averaging these two measurements after standardization (subtraction of the mean and division by the SD for the measurement) 12 A standardized carotid IMT that met or exceeded the sex-specific 80th percentiles in the sample, 13 an extreme increase of common carotid IMT, or presence of carotid artery stenosis ≥25% Extreme increase of common carotid artery IMT An extreme increase of common carotid IMT ≥1 mm 14 Carotid artery stenosis ≥25%
Presence of a stenosis of ≥25% in the internal or common carotid artery 13 
Peripheral arterial disease
Ankle-brachial index ≤0.9
Defined as the ratio of the average systolic blood pressure at the ankle of each leg divided by the average systolic blood pressure in the arm with the highest blood pressure.
An ankle-brachial index at or below 0.9 in either leg 13, 15 
Glomerular endothelial dysfunction
Microalbuminuria
An urine albumin-to-creatinine ratio ≥25 μg/mg in men, and ≥35 μg/mg in women 
